European Vaccine Research and Development Infrastructure

Project Information

TRANSVAC2

Grant agreement ID: 730964

DOI

10.3030/730964

Project closed

EC signature date 28 July 2017

Start date 1 May 2017

End date 30 April 2023

Funded under

• EXCELLENT SCIENCE - Research Infrastructures

Total cost

€ 14 556 732,34

EU contribution

€ 14 556 732,33

Coordinated by

EUROPEAN VACCINE INITIATIVE E.V
Germany

• Accelerating vaccine development for the fight against COVID-19
  DE EN ES FR IT PL